📈 Profit Update on Centene Corp. (CNC): 65% Options Gain on the $40 Strike Call

Date Published: 

When we issued our earlier analysis on Centene Corp. (CNC), the stock was spiraling lower. Shares had collapsed into the high $20s, and we highlighted that the panic-driven selloff created a rare asymmetric opportunity for options traders. Specifically, we recommended the Jan 2027 $40 Call as a high-upside LEAPS entry.

Today, CNC has rebounded into the mid-$30s, and the $40 call has surged in value — delivering substantial returns. Let’s revisit what has changed, compare old vs. new data, and quantify the gains.


🔙 CNC Back Then

At the time of our first callout:

  • Stock Price: ~$28–29
  • RSI: Deep oversold at ~25, a level historically tied to exhaustion selling.
  • MACD: Strongly negative, but showing early signs of flattening.
  • Options Chain: The $40 strike call was trading at just $3.90.

This was a contrarian setup — extreme fear combined with long-dated LEAPS at attractive pricing.




📊 CNC Now

Fast-forward to today:

  • Stock Price: ~$34.86
  • RSI: Back to ~67 on the daily chart, signaling bullish momentum from extreme lows.
  • MACD: Both daily and weekly MACD have flipped positive, confirming momentum shift.
  • Options Chain: The $40 strike call now trades at $6.45.




💰 Profit Breakdown

  • Old Price (Then): $3.90
  • New Price (Now): $6.45
  • Profit per Contract: $2.55
  • Total Dollar Profit (100 shares): $255
  • Percentage Gain: ~65%

That means a $390 investment in one contract has grown to $645, in just a few months.


🔍 Technical Comparison

  • Then: Oversold RSI, collapsing price, capitulation selling.
  • Now: RSI rebounded strongly, MACD bullish, volume accumulation visible. CNC has formed a higher base in the $30–35 range, strengthening the case for continued recovery.


🚦 Takeaway

Our CNC options thesis has played out as expected. If you had followed the recommendation to buy the Jan 2027 $40 Call, you’d now be up 65% on your position.

This highlights why LEAPS strategies in oversold, fundamentally stable companies can deliver outsized returns with relatively modest capital outlay.

The next key technical test will be the $35–38 resistance zone. If CNC breaks above, the $40 calls could move even deeper into the money, amplifying gains further.


Disclaimer: This update is for educational and informational purposes only. It does not constitute financial advice. Options trading involves substantial risk and may not be suitable for all investors. Always conduct your own due diligence and consult a licensed financial advisor before making any investment decisions.

Latest News for CNC

Centene Stock Soars 66% YTD: Should Investors Chase the Rally?

Centene Corporation CNC, one of the largest managed healthcare providers in the United States, has staged an impressive comeback in 2026. The stock has surged 66% year to date, far ahead of the industry's  28.5% gain.

Zacks Investment Research • Jul 14, 2026
CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

ST. LOUIS, July 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026, and host a conference call at 8:30 a.m.

PRNewsWire • Jul 10, 2026
Can Centene's Operational Execution Keep Margin Recovery on Track?

Centene Corporation's CNC margin recovery story appears to be shifting from strategy to execution. The company has rolled out several initiatives to better manage medical costs, modernize and standardize processes, and strengthen payment integrity.

Zacks Investment Research • Jul 9, 2026
CENTENE SUBSIDIARY MERIDIAN HEALTH PLAN OF ILLINOIS AWARDED ILLINOIS MEDICAID CONTRACT

ST. LOUIS, July 9, 2026 /PRNewswire/ -- Centene Corporation (Centene) (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing services for the HealthChoice Illinois Medicaid…

PRNewsWire • Jul 9, 2026

Analyst Price Targets — CNC

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
July 14, 2026 11:50 amDavid MacDonaldTruist Financial$78.00$68.29TheFly Centene price target raised to $78 from $71 at Truist
July 13, 2026 11:06 amWells Fargo$69.00$67.35TheFly Centene price target raised to $69 from $56 at Wells Fargo
July 7, 2026 11:08 amSarah JamesRaymond James$75.00$66.05TheFly Centene price target raised to $75 from $60 at Cantor Fitzgerald
June 23, 2026 11:01 amBen HendrixRBC Capital$70.00$63.67TheFly Centene initiated with a Sector Perform at RBC Capital
June 8, 2026 11:27 amMizuho Securities$63.00$62.33TheFly Centene price target raised to $63 from $58 at Mizuho
June 4, 2026 11:50 amErin WrightMorgan Stanley$57.00$59.55TheFly Centene price target raised to $57 from $50 at Morgan Stanley
June 1, 2026 11:25 amTruist Financial$71.00$59.59TheFly Centene price target raised to $71 from $58 at Truist
May 26, 2026 12:57 pmBarclays$75.00$57.65TheFly Centene price target raised to $75 from $63 at Barclays
May 22, 2026 11:13 amUBS$61.00$57.77TheFly Centene price target raised to $61 from $55 at UBS
May 20, 2026 10:44 amAnn HynesMizuho Securities$58.00$59.15TheFly Centene price target raised to $58 from $50 at Mizuho

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CNC.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top